Nanoparticle-Delivered Vaccine Candidate for COVID-19 Presents Potential in Preclinical Research

Medicine & Technology Mar 02, 2021

Researchers have developed a potential new nanoparticle-delivered COVID-19 vaccine that has presented strong effectiveness in preclinical illness models.

Pfizer, BioNTech Announce Completion of Phase 3 Study of COVID-19 Vaccine Candidate

Nov 19, 2020

Pfizer Inc. and BioNTech SE announced today that their COVID-19 vaccine candidate met all of the primary efficacy endpoints in their study.

Thousands of People Worldwide Sign up for COVID-19 Human Challenge Trials

Oct 12, 2020

Human challenge trials have been a part of developing cures for many diseases over the last century. A UK-based campaign called 1 Day Sooner are asking young people around the world to join the first coronavirus human challenge trials.

Novavax To Begin Phase 3 of Trials, Hopes To Soon Combine COVID-19 and Flu Vaccines

Sep 25, 2020

Novavax's vaccine candidate has produced the highest number of antibodies according to vaccine experts. As they enter the final stage of human trials, they will also be testing some participants with the flu vaccine at the same time.

Johnson & Johnson Vaccine Candidate To Begin Phase 3 of Human Trials

Sep 24, 2020

Johnson & Johnson will be entering phase three of human trials, including 60,000 participants from three continents. They also continue to look for other possible treatments for coronavirus as their vaccine candidate completes safety and efficacy trials.